The Risks and Dangers of Electronic Cigarettes

Aug.31.2022
The Risks and Dangers of Electronic Cigarettes
Electronic cigarettes are not a safe alternative to traditional smoking and may cause serious lung diseases.

For a long time, using e-cigarettes has been considered a reasonable option, as they are seen as a substitute for traditional cigarettes and a preferred choice for those who wish to quit smoking. Currently, e-cigarettes are facing scrutiny from the scientific community, and experts even suggest that they may be more harmful than traditional cigarettes.


According to a survey conducted by Covitel, a phone survey on risk factors for chronic non-communicable diseases during the pandemic, a significant portion of Brazilian youths use e-cigarettes. 19.7% of individuals aged 18 to 24 are followers of this device, which can be seen as one of the entry points for tobacco consumption.


Are electronic cigarettes riskier than regular cigarettes?


The Brazilian Society of Pathology (SBP) pathologist Alexandre Todorovic Fabro stated in a declaration that electronic cigarettes result in similar diseases as traditional cigarettes, as well as more severe conditions such as lung cell destruction due to combustion caused by the combination of hot steam and toxic substances.


Dr. Fabro compared the damage to lung tissue caused by electronic cigarettes to the toxic smoke inhalation experienced during fires, in order to provide evidence for the harm caused by e-cigarettes. He explained that in cases of this type of damage, "if the person does not die, they will develop pneumonia and leave marks on the lungs, much like internal scars.


In fact, there is a specific name for illnesses caused by the use of e-cigarettes: EVALI. In English, the full name for this term is e-cigarette or vaping product use-associated lung injury/illness, a term that has been in use since October 2019.


Other Complications Caused by Smoking


Aside from the unique diseases that electronic cigarettes may cause, they may also lead to the same issues as traditional cigarettes, such as lung cancer and chronic obstructive pulmonary disease (COPD) – previously known as emphysema. Concerning COPD, Paulo Antônio Morais Faleiros, a pulmonologist from SBP, explains that this is a preventable disease.


These two illnesses are most commonly seen among electronic cigarette users, but research linking this habit to an increased risk of over 10 types of cancer, including bladder cancer, has been conducted on cigarette smokers.


Electronic cigarettes can serve as a gateway to vaporizing.


Individuals who have been smoking for years do not prefer cigarettes with tutti-frutti scents or ones that taste like lemon pie. They prefer the taste and odor of tar. However, for those who have never smoked, these new flavors and aromas are clearly eye-catching," argued pulmonologist Dr. Faleiros.


At this point, it is difficult to observe that the device is actually a substitute for smoking cessation. On the other hand, research shows that electronic cigarettes are popular among young age groups, such as those aged 18 to 24.


Is the e-cigarette being released in Brazil?


It is important to note that Brazil has banned the use of electronic cigarettes. According to the Brazilian Medical Association (AMB) and the Federal Medical Council (CFM), legislation pertaining to electronic cigarettes should remain the same due to potential risks faced by users.


In July of this year, Brazil's National Health Surveillance Agency (Anvisa) declared that the ban on importing, advertising and selling electronic cigarettes and vaping devices would remain in effect following the release of a report on the subject. Despite these measures being taken, illegal sales of e-cigarettes and vaping devices continue to occur throughout the country.


Statement: 1. This article is compiled based on third-party information and is intended for industry exchange and learning. 2. The views expressed in this article do not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article contents. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of the compilation level, the compiled article may not express the same views as the original text, so please refer to the original text for accuracy. 4. Regarding any statements or positions related to domestic, Hong Kong, Macao, Taiwan, and foreign affairs, 2FIRSTS maintains full consistency with the Chinese government. 5. Copyright ownership of the compiled information belongs to the original media and authors. If any infringement is found, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | OLIVEBAR Launches RAZ PRO 85K, Combining Up to 85,000 Puffs With a Transparent Pod Design
Product | OLIVEBAR Launches RAZ PRO 85K, Combining Up to 85,000 Puffs With a Transparent Pod Design
OLIVEBAR has introduced the RAZ PRO 85K disposable vape, featuring up to 85,000 puffs, a transparent e-liquid pod, and a Mega HD display. As competition in the ultra-high-puff disposable segment continues to intensify, the new device reflects an industry shift from simply increasing puff counts toward enhancing visual interaction and user experience.
Jul.03
PMI U.S. Launches America250 Initiative, Introduces Limited-Edition ZYN Patriotic Storage Can
PMI U.S. Launches America250 Initiative, Introduces Limited-Edition ZYN Patriotic Storage Can
PMI U.S. launched its America250 initiative on June 1 to commemorate the 250th anniversary of the United States. As part of the program, the company introduced a limited-edition ZYN Patriotic Storage Can and released an IQOS U.S. Edition device. Beyond product-related activities, the initiative also includes innovation funding, nationwide events and community engagement programs.
PMI
Jun.05
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
Sesh touts independence, 8VC backing and retail reach as it challenges tobacco-owned pouch brands
U.S. nicotine pouch brand Sesh has emphasized its independence from Altria, Philip Morris International and British American Tobacco, along with backing from investors including 8VC, celebrity supporters and a retail footprint of more than 7,500 stores, as it seeks to differentiate itself in a market where major pouch brands are owned by large tobacco companies.
Regulations
Jul.07 by 2Firsts Perspectives
PMI Highlights 43 Million Smoke-Free Users at Stockholm Summit
PMI Highlights 43 Million Smoke-Free Users at Stockholm Summit
Philip Morris International says about 43 million adults worldwide now use its smoke-free products, with nearly 70% having stopped using cigarettes and smoke-free products accounting for about 43% of its net revenues.
Jun.18
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15